As the leading platform for biopharma regulated digital health solutions, BrightInsight accelerates time to market and ensures compliance for our customers, including Sanofi, Novo Nordisk, Roche, CSL Behring, UCB and others.
BrightInsight replaces the need for lengthy and complicated ‘build from scratch’ implementations and instead offers a pre-built and proven platform designed under a Quality Management System to support global security, privacy, and regulatory requirements.
The world’s leading biopharma companies trust the BrightInsight Platform for their regulated digital health products including apps, algorithms, medical devices, connected combination products, diagnostics, and Software as a Medical Device (SaMD).
"After conducting a rigorous evaluation, we selected BrightInsight because it has the only regulated solution with a robust Quality Management System and a comprehensive list of privacy and security certifications. BrightInsight’s Platform allows us to focus on therapeutic innovation, rather than the underlying digital technology."
Brian Johnson, Director, Digital Health, CSL Behring
Case Study
"Medical-grade digital health platforms like BrightInsight are key to helping us improve the conversation between people with diabetes and their caregivers."
Anders Dyhr Toft, Corporate Vice President, Commercial Innovation, Novo Nordisk
Learn More